rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-4-28
|
pubmed:abstractText |
Elevated total plasma homocysteine levels are associated with an increased risk of coronary artery disease. Plasma homocysteine levels are influenced by nutritional and hereditary factors. A point mutation (cytosin to thymidine substitution; C677-->T) in the gene encoding methylenetetrahydrofolate reductase (MTHFR), has been reported to render the enzyme thermolabile and has been associated with elevations in homocysteine levels in homozygous carriers (TT genotype).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-2972
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9502183-Adult,
pubmed-meshheading:9502183-Aged,
pubmed-meshheading:9502183-Case-Control Studies,
pubmed-meshheading:9502183-Coronary Disease,
pubmed-meshheading:9502183-Female,
pubmed-meshheading:9502183-Gene Frequency,
pubmed-meshheading:9502183-Genotype,
pubmed-meshheading:9502183-Germany,
pubmed-meshheading:9502183-Humans,
pubmed-meshheading:9502183-Male,
pubmed-meshheading:9502183-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:9502183-Middle Aged,
pubmed-meshheading:9502183-Oxidoreductases Acting on CH-NH Group Donors,
pubmed-meshheading:9502183-Point Mutation,
pubmed-meshheading:9502183-Risk Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease.
|
pubmed:affiliation |
Department of Internal Medicine, University of Jena, Germany. DREI@polkim.med.uni-jena.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|